FDA Inspection 1149614 — Octapharma Plasma Inc
The FDA completed an inspection of Octapharma Plasma Inc on July 29, 2021 in Hazelwood, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 29, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Hazelwood, MO (United States)